Smart investors know that if you want to make the big money off a small account, the place to be is the OTC Markets. There are many good OTC stocks that can boost your portfolio’s value in the long term. For investors, we preach the key to trading penny stocks is finding momentum BEFORE it happens and ahead of the crowd.
We alert our subscribers with our best ideas before our regular readers. This is the value of having a subscription to Insider Financial, which you can sign up for here.
If you watch the Insider Financial YouTube channel, you can get a sense of the ideal time to book profits. We warned our subscribers not to get greedy or get caught up in the diamond hands/paper hands BS.
We also recommend you own a portfolio of penny stocks. For some, that can be as many as 10 to 20 or more OTC stocks. This provides diversification and allows one to manage the market’s moods much easier. It also helps to own shares in the following 4 hot OTC stocks.
In this article, we look at 4 OTC stocks that will greatly reward patient investors. They are American Battery Technology Company (OTCQB: ABML), 88 Energy Limited (OTCPK: EEENF), Enzolytics Inc (OTCPK: ENZC), and HUMBL, Inc (OTCPK: HMBL).
OTC STOCKS #1 ABML
American Battery Technology Company, formerly known as American Battery Metals Corporation, has been correcting for months and found some support near the $1 mark. The OTCQB stock has declined by 22% over the month to trade at $1.16.
While it may be frustrating to hold this stock for so long without visible results, ABML is a good long-term bet that can quickly explode thanks to its unique position to lead the battery metals market. Despite the general bearishness, ABML has actually been a great success for our subscribers and readers.
We first paid attention to ABML in mid-February last year, when the share price was trading at only five pennies. You could have secured generous profits of over 3,000%, not to mention the potential profit of about 8,000% at the February peak near $5. This proves once again how subscribing to us can help you pick the best OTC stocks.
ABML is an advanced technology battery recycling and resource production company. It explores, mines, extracts, and recycles battery metals. It is focused on its Railroad Valley battery metal project in Nevada with the goal of becoming a substantial domestic supplier of battery metals to the increasing electric vehicles and battery storage markets in America.
Today, EV battery recycling is becoming a necessity due to the increasing demand for EVs and plug-in hybrid cars, whose batteries will eventually have to be recycled to prevent an environmental catastrophe.
Recently, the $770 million company changed its name and appointed a new CEO.
ABML shared an important update earlier this month when it announced the preliminary sampling results at its 305 lode mining claims located on land administered by the Bureau of Land Management (BLM) in Little Smokey Valley near Tonopah, Nevada.
The company’s field team analyzed 29 new surface sample locations, along with existing samples previously collected by other parties, and the resulting data demonstrated grades of anomalous reported lithium present from 260 ppm to 1,530 ppm in the project area. Samples with values of 300 ppm and up are typically considered very prospective in nature. The samples were analyzed by ALS Analytical Lab in Reno Nev., and the samples collected by ABML were assayed at the American Assay Laboratory in Reno, Nev.
ABML CEO Ryan Melsert said:
“We are excited to confirm the attractive lithium concentrations in these surface samples throughout our claims. With these initial surface sample characterizations completed, we can now take the important next step of subsurface sampling to determine the potentiality of even greater attractive concentrations and overall compositions of these sedimentary deposits as experienced on nearby claims at shallow depths.”
Exploratory subsurface sampling is the next sequential step in moving towards developing this resource, where the sample results will be used to define the extent of the deposit in footprint, depth, and the grades of the lithium.
Previously, we reported that ABML had received a competitively bid $2 million contract award from the United States Advanced Battery Consortium LLC (USABC), in collaboration with the US Department of Energy (DOE), for the commercial demonstration of its integrated lithium-ion battery recycling system and production of battery cathode grade metal products, the synthesis of high energy density active cathode material from these recycled battery metals by cathode producer and lithium-ion battery recycler BASF, and then the fabrication of large format automotive battery cells from these recycled materials and the testing of these cells against otherwise identical cells made from virgin sourced metals by cell technology developer C4V.
Meanwhile, in mid-November, ABML said that it continued to make construction progress on its pre-commercial battery recycling plant in Fernley, Nevada, receiving approval of its Core and Shell Building Permit and achieving a major construction milestone. Now it prepares for the next step of the project, including construction of the production building, laboratories, and office space.
Today on site: pouring the main slab for the Phase 1 Production Building, the first of 3 major concrete pours for that slab. Check our Instagram feed (@abt_company) for videos of the action, now embedded on our website here: https://t.co/gLZXrn8MgC $ABML @MilesConst pic.twitter.com/NFeHRgE0lp
— American Battery Technology Company (@abt_company) December 7, 2021
All in all, ABML relies on some strong fundamentals that will show results in the future, so be patient and get ready to reap the coming rewards.
OTC STOCKS #2 EEENF
88 Energy Limited is also trying to find a reliable support level after correcting since August. The share price of the Pink Current stock has declined by over 10% since mid-Nover, currently trading at $0.0179.
Our readers are already familiar with EEENF, as we shared our bullish expectations on several occasions. We shared our take on the OTC stock in March, well before the YTD high touched in April, which demonstrates why it makes sense to subscribe with us.
88 Energy is exploring oil and gas properties in Alaska and is now very close to confirming the existence of oil in one of its fully owned sites. In Alaska, EEENF now holds a 59% working interest in the Icewine project, which covers an area of about 231,000 acres, a 100% working interest in the Yukon Gold leases with an area of 15,235 acres, and another 100% working interest in the Peregrine project, with an area of about 195,373 acres.
Investors have been closely watching the Peregrine project after the company announced that it would test the Merlin exploration well by drilling. Earlier this year, it launched operations and confirmed the potential existence of hydrocarbon-bearing zones at the site. On June 24, the company said that geochemical analysis of fluid extracts from selected core samples definitively demonstrated the presence of hydrocarbons. Next, EEENF will continue with the quantitative screening on remaining samples and start phase two of side-wall core trim analysis, including quantitative extraction, SARA, isotopes, and biomarker analysis.
On Monday, 88 Energy announced some progress on the Merlin-2 project, which will be drilled in the first quarter of 2022. Operations remain on track for the spud of the Merlin-2 appraisal well in February 2022, with snow road construction preparations underway and construction expected to commence prior to the end of 2021, subject to weather conditions. Pre-commissioning inspection of the Arctic Fox rig is planned for early January, with an inspection prior to contracting the rig confirming it to be in excellent condition. Commissioning of the rig is expected to occur following the rig inspection in January 2022 and immediately prior to mobilization to the Merlin-2 drill site. The Merlin-2 appraisal is targeting 652 million barrels of oil in the highly prospective N18, N19, and N20 targets that were encountered in the successful Merlin-1 well (drilled in March 2021 to a depth of 5,267 feet), which demonstrated the presence of oil in these multiple stacked sequences within the Brookian Nanushuk Formation.
In August, the company provided some updates on its Umiat oil field, which it acquired earlier this year. EEENF, via its wholly-owned subsidiary Emerald House LLC, which owns 100% of Umiat oil field leases AA-084141 and AA-081726 (Umiat Unit Leases), got notified from the Bureau of Land Management of approval of its request for a 24-month extension to the Year 2 Unit Obligations, and corresponding extensions for the Unit obligations in Years 3, 4 and 5.
Even though EEENF is only at the exploration phase, the $265 million company is still undervalued. The fact that EEENF’s largest shareholders include subsidiaries of Merrill Lynch, Citigroup, BNP Paribas, and JPMorgan is very telling. Also, the top 20 shareholders have increased their stake this year.
Oil is currently $75.61 and headed North. Are you setting yourself up for Financial Freedom? @88EnergyLtd is a perfect way start that journey with $EEENF in your portfolio. They’re Debt Free & Workers accepting Shares as payment. Scale in while you can before it goes wild in 2022 pic.twitter.com/IWQdfjs3sC
— ★ Mike Van Horn Sr ★ (@DaCowboysRock) December 8, 2021
EEENF is a long-term bet and a discount entry opportunity at current levels.
OTC STOCKS #3 ENZC
Enzolytics Inc has lost almost a third of its value during the last 30 days alone, breaking below the $0.1 mark for the first time since April. At the time of writing, the Pink Current stock is trading at 0.0944. Should this be a moment of disappointment for investors? On the contrary, this is a great opportunity to get the stock for a bargain price and buy the dip as we always preach.
We don’t cease to be bullish on ENZC despite the fact that larger timeframes point to a long-term correction since February.
We got our subscribers in on ENZC last year in October at just $.014 a share, helping many of our subscribers secure generous profits before the correction from the YTD high. We expect another rally next year, as ENZC is developing multiple therapies and has pending patents.
Last year, ENZC merged with BioClonetics, laying the foundation of collaboration of two experienced teams developing treatments against infectious diseases.
ENZC patented anti-HIV therapeutics and applies its proprietary methodology to produce human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. ENZC has tested its anti-HIV therapeutics and has developed a proprietary cell line that generates human monoclonal antibodies that neutralize HIV. We explained in an extensive analysis why ENZC’s HIV therapeutics are better than Gilead’s products that have monopolized the space.
Following the merger with BioClonetics, ENZC adopted its proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases, including HIV, influenza A, influenza B, rabies, tetanus, diphtheria, and even the coronavirus causing COVID-19.
Last month, ENZC announced planned production and sale in the US and the rest of North America of ‘Enzolytics IPF Immune’, a liquid nutritional supplement that is an immune modulator that benefits the immune system by fortifying it against infections and supporting the body’s antioxidant defense. The active components in the supplement have been registered with the FDA for use in the US under NDI reg. no. 1083. The product will be produced and sold by ENZC pursuant to its license under US Patent No. 8,309,072 (the ‘072 Patent), entitled “Irreversibly-Inactivated Pepsinogen Fragments for Modulating Immune Function”. It covers the use of Irreversibly Inactivated Pepsin Fragments (IPF) which has been shown in tests to perform an immune-modulating function.
Earlier in December, ENZC provided an update on some of its products. It said that it was advancing two platforms addressing AIDS – one being a clinically tested, patented, antiviral therapeutic known as ITV-1, that has shown significant effectiveness in treating patients with HIV/AIDS. This therapeutic is complementary to the company’s development of fully human monoclonal antibodies that target and neutralize the virus.
In response to your numerous inquiries: yes, we confirm again that we are ready to start sales in Africa of the Enzolytics product – ITV-1 in year 2022. No FDA or EMA registration will be required for that market.
— Enzoimmune Active (@enzoimmune) December 7, 2021
ENZC is using AI to identify immutable sites on 20 viruses, including COVID.
We think ENZC is undervalued and has some great potential to reach the $1 and get uplisted sooner than later. With so many treatment solutions and the innovative technology it leverages, ENZC is poised to become a leader in several markets.
OTC STOCKS #4 HMBL
HUMBL, Inc is the only OTC stock from our list that has shown some signs of optimism during the last few days, gaining 10% over the week and 4% on Wednesday alone. However, the $390 million company is still over 30% down since mid-November.
We covered HMBL in a dedicated article in November 2020, shortly after the company became public as a result of a merger. Any that bought on the back of overage at $.027 and held into February would have seen potential gains of over 28,000%!! This is another example demonstrating why you should consider subscribing to Insider Financial.
HUMBL is a web 3 platform whose goal is to connect consumers and merchants in the digital economy across its HUMBL Mobile Applications, HUMBL Marketplace, and HUMBL Financial divisions. HUMBL Mobile Applications deliver more seamless global transactions, by integrating multiple currencies, payment methods, and financial services.
HUMBL Marketplace was developed to connect customers and merchants online, in improved global commerce, deal discovery and blockchain tokenization programs. HUMBL Financial has developed new software and algorithms for the digital asset trading markets, which represent a new global market for blockchain technologies, and will also offer other credit, lending and financial services, although the products are not available in the US and a few other jurisdictions.
Recently, George Sharp returned to HMBL as Capital Markets Advisor to help it advance to the OTCQB tier and then towards an application to the NASDAQ Stock Market. In furtherance of these milestones, the company will file audited financials with the SEC beginning with the yearend statement for 2021.
At the end of November, HMBL announced the newest release of the ‘HUMBL Pay’ mobile wallet, including the latest upgrades to its P2P functionalities, and additional features that simplify the management of digital assets and blockchain functionality. Under this release, which is now available on the Apple App Store and Google Play Store, HUMBL Pay users can:
- Purchase digital assets via major credit cards inside the HUMBL Pay mobile wallet;
- Send digital assets such as BTC, ETH, and USDC between HUMBL mobile wallets;
- Perform gasless digital asset transactions between HUMBL mobile wallets;
- Earn as much as 7% interest on various digital assets.
The HUMBL technology team is also working to accommodate P2P transactions across major government-issued fiat currencies, such as the US Dollar (USD) and additional blockchain-authenticated integrations.
— HUMBL (@HUMBLPay) November 23, 2021
HUMBL President and CEO, Brian Foote, said:
“Our mission for the HUMBL Pay wallet is to create simple, blockchain pathways for global consumers. We have now achieved another key milestone on that path.”
All in all, HMBL is on the right path, as it taps into the fast-growing blockchain market, providing users with a range of solutions that address actual problems. HMBL is an NFT play as well after launching its NFT Gallery in September. The company is backed by strong fundamentals that could propel it to new highs in 2022.
THE FINAL NOTE
All of the 4 OTC stocks discussed today have been beaten down and are good stocks to hold. The upside is much greater than the downside at these levels.
It’s also very important to eye OTC stocks that have yet to make their explosive move. There are plenty of opportunities, and we take our time to monitor hundreds of penny stocks to buy each week, trying to find the best alerts for our subscribers.
Remember, all you need is one or two penny stocks to succeed in order to crush the market averages.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.